CoChat

Induction of eotaxin production by interleukin‐4, interleukin‐13 and lipopolysaccharide by nasal fibroblasts

Nonaka, M., Pawankar, R., Fukumoto, A., Ogihara, N., Sakanushi, A., Yagi, T. · 2004 · Clinical & Experimental Allergy
Cited by 47

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Background There is growing evidence that eotaxin is a key mediator in the development of tissue eosinophilia. Fibroblasts are a major source of eotaxin. The severity of diseases with eosinophilic inflammation like nasal polyposis, atopic dermatitis and asthma, where Th2‐type cytokines (IL‐4 and IL‐13) and TGF‐β are expressed locally, was shown to correlate with bacterial factors such as lipopolysaccharide (LPS) rather than allergen. Objective We examined eotaxin production by nasal fibroblasts stimulated with IL‐4 or IL‐13 alone or in combination with LPS, and the effect of TGF‐β 1 on it. Moreover, we compared the magnitude of eotaxin produced by nasal fibroblasts with that produced by lung or skin fibroblasts. Methods Fibroblast lines were established from human biopsy tissue. The expression of eotaxin mRNA was evaluated by RT‐PCR. The amount of eotaxin in the supernatants was measured by ELISA. Results IL‐4, but not IL‐13, synergized with LPS to produce eotaxin in a dose‐ and time‐dependent manner. Sequential treatment of nasal fibroblasts with IL‐4 and LPS did not have any effect. But when IL‐4 and LPS were added together, synergy for eotaxin production was observed. Moreover, this synergy was observed in nasal and skin fibroblasts, but not in lung fibroblasts. The production of eotaxin by IL‐4 and LPS was modulated by TGF‐β 1. Conclusion These results suggest that a co‐stimulus like LPS is necessary for IL‐4 to make a strong induction of eotaxin in eosinophilic inflammations such as nasal polyposis. Modulation by TGF‐β 1 may have important implications for the development of eosinophilic inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2222.2004.1954.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 47

Metadata

Authors
Nonaka, M., Pawankar, R., Fukumoto, A., Ogihara, N., Sakanushi, A., & Yagi, T.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2004-05
Volume
34
Issue
5
Pages
804-811
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2115794953
Cited by
47
References
3
FWCI
2.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Induction of eotaxin production by interleukin‐4, interleukin‐13 and lipopolysaccharide by nasal fibroblasts. https://app.cochat.ai/papers/10.1111/j.1365-2222.2004.1954.x
The paper
Nonaka, M., Pawankar, R., Fukumoto, A., Ogihara, N., Sakanushi, A., & Yagi, T. (2004). Induction of eotaxin production by interleukin‐4, interleukin‐13 and lipopolysaccharide by nasal fibroblasts. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2004.1954.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.